Effect of bovine fibroblast interferon on rhinovirus infection in calves

Bruce D. Rosenquist From the Department of Veterinary Microbiology, College of Veterinary Medicine, University of Missouri, Columbia MO 65211.

Search for other papers by Bruce D. Rosenquist in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
and
Gary K. Allen From the Department of Veterinary Microbiology, College of Veterinary Medicine, University of Missouri, Columbia MO 65211.

Search for other papers by Gary K. Allen in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Click on author name to view affiliation information

Summary

The prophylactic/therapeutic activity of natural bovine fibroblast interferon (BoF-ifn) against bovine rhinovirus infection in calves was assessed. Six calves were each given 8 intranasal inoculations of partially purified BoF-ifn (3.25 × 105 U at 8 am, 11 am, 5 pm, and 8 pm on day 1 and 8 am, 11 am, 2 pm, and 5pm on day 2), and 6 calves were given placebo. All calves were challenge exposed with 105.1 TCID 50) of bovine rhinovirus after the first 2 treatments (6 hours after the first ifn or placebo treatment). Nasal excretion of rhinovirus, ifn concentration in the nasal secretions, and nasal secretion and serum rhinovirus antibodies were measured before and at selected times after calves were inoculated. Interferon-treated calves excreted rhinovirus in their nasal secretions in lesser amounts (mean value, 0.84 log10 TCID 50/ml vs 1.58 log10 TCID 50/ml on postchallenge exposure days 1 and 2; (P < 0.05) and for a shorter duration (P < 0.05) than did placebo-treated calves. No calves developed clinical signs of respiratory tract illness. Rhinovirus antibody titer was not significantly different between ifn- and placebo-treated calves.

Summary

The prophylactic/therapeutic activity of natural bovine fibroblast interferon (BoF-ifn) against bovine rhinovirus infection in calves was assessed. Six calves were each given 8 intranasal inoculations of partially purified BoF-ifn (3.25 × 105 U at 8 am, 11 am, 5 pm, and 8 pm on day 1 and 8 am, 11 am, 2 pm, and 5pm on day 2), and 6 calves were given placebo. All calves were challenge exposed with 105.1 TCID 50) of bovine rhinovirus after the first 2 treatments (6 hours after the first ifn or placebo treatment). Nasal excretion of rhinovirus, ifn concentration in the nasal secretions, and nasal secretion and serum rhinovirus antibodies were measured before and at selected times after calves were inoculated. Interferon-treated calves excreted rhinovirus in their nasal secretions in lesser amounts (mean value, 0.84 log10 TCID 50/ml vs 1.58 log10 TCID 50/ml on postchallenge exposure days 1 and 2; (P < 0.05) and for a shorter duration (P < 0.05) than did placebo-treated calves. No calves developed clinical signs of respiratory tract illness. Rhinovirus antibody titer was not significantly different between ifn- and placebo-treated calves.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 33 33 6
PDF Downloads 21 21 1
Advertisement